Purdue Pharma Reach Tentative Deal in Opioid Crisis Lawsuit
Purdue Pharma, the company responsible for the drug Oxycontin, reached a tentative billion dollar deal to resolve thousands of lawsuits.
The new settlement means that Purdue Pharma will likely avoid going to trial.
That’s after they were sued by more than 23 hundred local governments and 23 states.
Details on how the settlement will be divided up have not been determined.
Under the agreement, any future revenue of Oxycontin would go towards helping communities struggling with the opioid epidemic.
More than a dozen drug manufactures are facing similar charges.